CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
NextFerm develops AstaFerm™, a highly concentrated and bioavailable form of Astaxanthin, a natural antioxidant. This innovative dietary supplement aims to reduce oxidative stress, which is linked to various age-related diseases, by providing a more effective and palatable option for consumers.
Oxidative stress is an imbalance between the production of reactive oxygen species and the ability of the human body to counteract their harmful effects through neutralization by antioxidants.
Oxidative stress is the major cause of the cellular damage at the basis of age-related diseases, such as atherosclerosis, cancer, diabetes, rheumatoid arthritis, cardiovascular diseases, chronic inflammations, stroke and other degenerative diseases.
The best way to reduce oxidative stress is the intake of…
NEXTFERM TECHNOLOGIES LTD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
